Townsend Richard Nolan

Insider profile

Performance

Overall performance
3.6

Performance over holding periods
3.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Townsend Richard Nolan's trades of Lexeo Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-01 2026-07-01 S Sale
5,581 +41.3%
176.82
US$2,650,492
5,581 +41.3% 176.82 US$2,650,492
2026-07-01 2026-07-01 PrS Proposed sale
51,127
201.34
US$1,620,165
51,127 201.34 US$1,620,165
2026-05-20 2026-05-18 S Sale
80,585 +19.2%
430.31
US$3,241,545
80,585 +19.2% 430.31 US$3,241,545
2026-05-18 2026-05-18 PrS Proposed sale
3,342
5.06
US$16,927
3,342 5.06 US$16,927
2026-04-07 2026-04-06 PlS Planned sale
55,000 -13.9%
5.69
US$313,137
55,000 -13.9% 5.69 US$313,137
2026-04-06 2026-04-06 PrS Proposed sale
55,000
5.72
US$314,600
55,000 5.72 US$314,600
2026-02-20 2026-02-18 S Sale
10,173 -2.5%
6.38
US$64,924
10,173 -2.5% 6.38 US$64,924
2026-02-18 2026-02-18 PrS Proposed sale
11,374
6.38
US$72,585
11,374 6.38 US$72,585
2025-11-20 2025-11-18 S Sale
1,127 -0.5%
9.27
US$10,447
1,127 -0.5% 9.27 US$10,447
2025-11-18 2025-11-18 PrS Proposed sale
1,127
9.27
US$10,452
1,127 9.27 US$10,452
2025-10-17 2025-10-17 PrS Proposed sale
13,133
8.94
US$117,437
13,133 8.94 US$117,437
2025-10-17 2025-10-17 S Sale
148 -0.1%
9.56
US$1,415
148 -0.1% 9.56 US$1,415
2025-10-17 2025-10-17 S Sale
12,985 -5.1%
8.94
US$116,021
12,985 -5.1% 8.94 US$116,021
2025-08-20 2025-08-18 S Sale
2,735 -1.2%
4.67
US$12,767
2,735 -1.2% 4.67 US$12,767
2025-08-18 2025-08-18 PrS Proposed sale
1,115
4.67
US$5,205
1,115 4.67 US$5,205
2025-05-20 2025-05-16 S Sale
1,074 -0.5%
2.77
US$2,979
1,074 -0.5% 2.77 US$2,979
2025-05-16 2025-05-16 PrS Proposed sale
1,074
2.77
US$2,980
1,074 2.77 US$2,980
2025-02-21 2025-02-19 S Sale
4,326 -1.9%
4.41
US$19,091
4,326 -1.9% 4.41 US$19,091
2025-02-19 2025-02-19 PrS Proposed sale
4,326
4.41
US$19,091
4,326 4.41 US$19,091
2024-12-12 2024-12-10 PlS Planned sale
2,500 -2.0%
8.20
US$20,491
2,500 -2.0% 8.20 US$20,491
2024-12-10 2024-12-10 PrS Proposed sale
2,500
8.24
US$20,600
2,500 8.24 US$20,600
2024-11-13 2024-11-11 PlS Planned sale
2,500 -2.0%
7.82
US$19,557
2,500 -2.0% 7.82 US$19,557
2024-10-15 2024-10-10 PlS Planned sale
5,000 -4.0%
8.10
US$40,496
5,000 -4.0% 8.10 US$40,496
2024-09-11 2024-09-10 PlS Planned sale
5,000 -4.0%
10.65
US$53,274
5,000 -4.0% 10.65 US$53,274
2024-09-10 2024-09-10 PrS Proposed sale
12,500
10.79
US$134,875
12,500 10.79 US$134,875
2024-08-13 2024-08-12 PlS Planned sale
5,000 -4.0%
11.53
US$57,634
5,000 -4.0% 11.53 US$57,634
2024-07-12 2024-07-11 PlS Planned sale
100 -0.1%
19.06
US$1,906
100 -0.1% 19.06 US$1,906
2024-07-12 2024-07-11 PlS Planned sale
27,931 -18.8%
17.06
US$476,503
27,931 -18.8% 17.06 US$476,503
2024-07-12 2024-07-10 PlS Planned sale
3,347 -2.2%
16.85
US$56,397
3,347 -2.2% 16.85 US$56,397
2024-07-12 2024-07-10 PlS Planned sale
23,622 -13.4%
16.45
US$388,582
23,622 -13.4% 16.45 US$388,582
2024-06-12 2024-06-10 PlS Planned sale
2,038 -1.2%
18.18
US$37,051
2,038 -1.2% 18.18 US$37,051
2024-06-12 2024-06-10 PlS Planned sale
2,962 -1.7%
17.29
US$51,213
2,962 -1.7% 17.29 US$51,213
2024-05-14 2024-05-13 PlS Planned sale
5,000 -2.8%
13.22
US$66,093
5,000 -2.8% 13.22 US$66,093
2024-05-13 2024-05-13 PrS Proposed sale
70,000
13.25
US$927,500
70,000 13.25 US$927,500